Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Intubation	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
an	O
___	O
with	O
h/o	O
systolic	O
CHF	O
(LVEF	O
35-40%	O
in	O
___,	O
COPD,	O
CAD,	O
AF	O
on	O
ASA,	O
bradycardia	O
s/p	O
___	O
placement	O
transferred	O
on	O
___	O
from	O
___,	O
where	O
he	O
was	O
intubated	O
for	O
respiratory	O
distress,	O
after	O
p/w	O
SOB	O
x4	O
days.	O
He	O
initially	O
presented	O
to	O
___	O
with	O
SOB	O
at	O
rest	O
and	O
on	O
minimal	O
exertion	O
x4	O
days.	O
He	O
reports	O
that	O
at	O
baseline,	O
he	O
has	O
no	O
SOB	O
at	O
rest	O
or	O
on	O
ambulation	O
on	O
2L	O
NC	O
home	O
oxygen,	O
noting	O
that	O
he	O
experiences	O
dyspnea	O
only	O
when	O
hammering	O
or	O
doing	O
other	O
strenuous	O
activity;	O
he	O
denies	O
orthopnea/PND	O
or	O
peripheral	O
edema	O
either	O
at	O
baseline	O
or	O
in	O
the	O
setting	O
of	O
his	O
recent	O
OSH	O
presentation.	O
He	O
endorses	O
occasional	O
nonproductive	O
cough,	O
duration	O
uncertain,	O
as	O
well	O
as	O
rhinorrhea,	O
but	O
denies	O
f/c,	O
CP,	O
pleuritic	O
CP,	O
wheeze,	O
sick	O
contacts,	O
or	O
dietary	O
indiscretion.	O
On	O
arrival	O
to	O
the	O
OSH	O
ED,	O
oxygen	O
saturation	O
was	O
reportedly	O
88%,	O
prompting	O
intubation	O
for	O
respiratory	O
distress	O
and	O
confusion	B-Delirium
and	O
subsequent	O
transfer	O
to	O
___	O
for	O
further	O
management;	O
DD	O
reportedly	O
4.55.	O
On	O
arrival	O
to	O
___,	O
he	O
was	O
intubated	O
and	O
sedated	O
on	O
propofol	O
with	O
rhonchorous	O
BS.	O
Initial	O
VS	O
were	O
as	O
follows:	O
97,	O
60,	O
112/61,	O
16,	O
98%	O
on	O
MV	O
(TV	O
=	O
450,	O
RR	O
=	O
16,	O
FiO2	O
=	O
50%,	O
PEEP	O
=	O
5).	O
Admission	O
labs	O
were	O
notable	O
for	O
negative	O
TnT,	O
BNP	O
to	O
9478,	O
and	O
UA	O
with	O
few	O
bacteria	O
and	O
positive	O
leukocytes.	O
ABG	O
was	O
7.37/61/133/37.	O
CXR	O
was	O
notable	O
for	O
diffuse	O
infiltrates	O
concerning	O
for	O
CHF	O
v.	O
COPD	B-Lower_respiratory_tract_infection
exacerbation.	B-Lower_respiratory_tract_infection
Head	B-Intracranial_haemorrhage
CT	B-Intracranial_haemorrhage
was	O
negative	O
for	O
acute	O
intracranial	B-Intracranial_haemorrhage
process,	O
and	O
CT-A	O
was	O
negative	O
for	O
PE,	O
but	O
notable	O
for	O
moderate	O
emphysema,	O
bibasilar	O
atelectasis,	O
and	O
moderate	O
cardiomegaly	O
with	O
a	O
small	O
pericardial	O
effusion.	O
He	O
received	O
Lasix,	O
nitropaste,	O
methylprednisolone,	O
azithromycin,	O
and	O
Combivent	O
nebs.	O
Past	O
Medical	O
History:	O
CHF	O
(LVEF	O
35-40%	O
in	O
___	O
COPD	O
CAD	O
AF	O
on	O
ASA	O
due	O
to	O
h/o	O
falls	B-Falls
Bradycardia	O
s/p	O
___	O
placement	O
Dementia	B-Dementia
HTN	O
BPH	O
s/p	O
AAA	O
repair	O
s/p	O
cataract	B-Visual_impairment
surgery	O
glaucoma	B-Visual_impairment
Social	O
History:	O
___	O
Family	O
History:	O
Unable	O
to	O
elicit.	O
Physical	O
Exam:	O
ADMISSION	O
EXAM	O
General:	O
Intubated	O
and	O
sedated	O
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
PERRL	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Lungs:	O
Wheezes	O
and	O
ronchi	O
throughout	O
Abdomen:	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
organomegaly	O
GU:	O
no	O
foley	O
Ext:	O
WWP	O
2+	O
pulses	O
palpable	O
bilaterally,	O
hyperpigmentation	O
c/w	O
chronic	O
venous	O
stasis	O
changes,	O
L>R,	O
with	O
pitting	O
edema	O
bilaterally	O
to	O
mid-calves	O
Neuro:	O
Deferred	O
DISCHARGE	O
EXAM	O
VS	O
Tm	O
98.7	O
Tc	O
97.2	O
BP	O
117/53	O
(110s-120s)	O
HR	O
61	O
(50s-70s)	O
RR	O
18	O
95%	O
RA	O
GEN	O
Alert,	O
oriented	B-Unspecified_cognitive_impairment
only	B-Unspecified_cognitive_impairment
to	B-Unspecified_cognitive_impairment
self,	B-Unspecified_cognitive_impairment
no	O
acute	O
distress	O
HEENT	O
MMM,	O
EOMI,	O
sclera	O
anicteric,	O
OP	O
clear	O
NECK	O
supple,	O
JVP	O
difficult	O
to	O
apprehend	O
due	O
to	O
habitus/neck	O
positioning	O
PULM	O
Good	O
aeration,	O
no	O
wheezes,	O
no	O
crackles,	O
no	O
rhonchi	O
CV	O
RRR	O
normal	O
S1/S2,	O
no	O
mrg	O
ABD	O
soft	O
NT	O
ND	O
normoactive	O
bowel	O
sounds,	O
no	O
r/g	O
EXT	O
WWP	O
2+	O
pulses	O
palpable	O
bilaterally,	O
hyperpigmentation	O
c/w	O
chronic	O
venous	O
stasis	O
changes,	O
no	O
peripheral	O
edema	O
NEURO	O
A0x1,	B-Unspecified_cognitive_impairment
pleasantly	O
tangential,	O
motor	O
function	O
grossly	O
normal	O
Pertinent	O
Results:	O
On	O
admission:	O
UA:	O
1	O
rbc,	O
<1	O
wbc,	O
few	O
bacteria,	O
neg	O
nitrite/leuks,	O
30	O
protein	O
CBC:	O
5	O
(90.2P)/37.1/114	O
Cardiac	O
studies:	O
TnT	O
<0.01,	O
proBNP	O
9478	O
Lytes:	O
138/5.8	O
___	O
ABG:	O
7.37/61/133/37,	O
lactate	O
1.2	O
(intubated,	O
FiO2	O
100%)	O
LFTs:	O
___	O
At	O
discharge:	O
CBC:	O
6.6/43.4/130	O
Lytes:	O
139/___/38/34/1.4/170	O
Noncontrast	O
head	B-Intracranial_haemorrhage
CT	B-Intracranial_haemorrhage
(___):	O
No	O
evidence	O
of	O
acute	O
intracranial	B-Intracranial_haemorrhage
process.	O
CT-A	O
chest	O
(___):	O
1.	O
No	O
evidence	O
of	O
pulmonary	O
embolism.	O
2.	O
Moderate	O
emphysema.	O
3.	O
Bibasilar	O
atelectasis	O
with	O
secretion/aspiration	O
seen	O
within	O
left	O
mainstem	O
and	O
right	O
maintstem	O
bronchus	O
and	O
bronchi	O
to	O
the	O
right	O
lower	O
lobe.	O
4.	O
Moderate	O
cardiomegaly	O
and	O
small	O
pericardial	O
effusion.	O
5.	O
Ascending	O
thoracic	O
aortic	O
dilation.	O
Enlarged	O
main	O
pulmonary	O
artery	O
which	O
may	O
indicate	O
pulmonary	O
hypertension.	O
TTE	O
(___):	O
The	O
left	O
atrium	O
is	O
moderately	O
dilated.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
(LVEF>55%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
root	O
is	O
mildly	O
dilated	O
at	O
the	O
sinus	O
level.	O
The	O
ascending	O
aorta	O
is	O
mildly	O
dilated.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
Mild	O
to	O
moderate	O
(___)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Suboptimal	O
image	O
quality.	O
Mild-moderate	O
aortic	O
regurgitation.	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
preserved	O
regional	O
and	O
global	O
biventricular	O
systolic	O
function.	O
Pulmonary	O
artery	O
hypertension.	O
Dilated	O
ascending	O
aorta.	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
is	O
an	O
___	O
with	O
h/o	O
systolic	O
CHF	O
(LVEF	O
35-40%	O
in	O
___,	O
COPD,	O
CAD,	O
AF	O
on	O
ASA,	O
bradycardia	O
s/p	O
___	O
placement	O
transferred	O
on	O
___	O
from	O
___,	O
where	O
he	O
was	O
intubated	O
for	O
respiratory	O
distress,	O
after	O
p/w	O
SOB	O
x4	O
days,	O
now	O
breathing	O
well	O
post-extubation.	O
#Hypoxemic	O
respiratory	O
failure:	O
He	O
presented	O
from	O
an	O
OSH	O
intubated	O
and	O
sedated	O
and	O
received	O
aggressive	O
diuresis	O
for	O
CHF	O
(noted	O
below),	O
as	O
well	O
as	O
steroids	O
for	O
COPD	B-Lower_respiratory_tract_infection
exacerbation	B-Lower_respiratory_tract_infection
(noted	O
below).	O
He	O
was	O
extubated	O
successfully	O
on	O
___	O
without	O
fever,	O
HD	O
instability,	O
leukocytosis,	O
or	O
other	O
e/o	O
infection	O
throughout	O
admission.	O
#Acute-on-chronic	O
CHF:	O
Patient	O
with	O
known	O
sytolic	O
CHF	O
(LVEF	O
35-40%	O
in	O
___	O
p/w	O
clinical	O
e/o	O
fluid	O
overload	O
and	O
CXR	O
with	O
prominent	O
pulmonary	O
vasculature	O
in	O
the	O
absence	O
of	O
clear	O
inciting	O
event.	O
He	O
was	O
diuresed	O
with	O
IV	O
Lasix,	O
with	O
good	O
effect,	O
followed	O
by	O
80mg	O
PO	O
daily,	O
up	O
from	O
his	O
home	O
dose	O
of	O
40mg	O
PO	O
daily,	O
with	O
resulting	O
mild	O
hypervolemia	O
and	O
return	O
to	O
his	O
home	O
supplemental	O
oxygen	O
requirement	O
of	O
2L,	O
prompting	O
transfer	O
from	O
the	O
MICU	O
to	O
the	O
medical	O
floor.	O
On	O
attainment	O
of	O
euvolemia	O
on	O
the	O
floor,	O
his	O
home	O
dose	O
of	O
Lasix	O
40mg	O
PO	O
daily	O
was	O
continued.	O
Home	O
atenolol	O
and	O
lisinopril	O
were	O
continued.	O
TTE	O
demonstrated	O
mild-moderate	O
AR,	O
mild	O
symmetric	O
LVH	O
with	O
preserved	O
regional	O
and	O
global	O
biventricular	O
systolic	O
function	O
(LVEF	O
>55%),	O
mild	O
PA	O
HTN,	O
and	O
dilated	O
ascending	O
aorta.	O
By	O
the	O
time	O
of	O
discharge,	O
he	O
was	O
breathing	O
comfortable	O
without	O
supplemental	O
oxygen	O
requirement.	O
#COPD:	O
Patient	O
with	O
known	O
COPD	O
was	O
noted	O
to	O
be	O
hypercarbic	O
while	O
ventilated.	O
He	O
initially	O
received	O
methylprednisolone,	O
followed	O
by	O
prednisone	O
burst	O
30mg	O
x5	O
days,	O
though	O
azithromycin	O
was	O
held	O
following	O
an	O
initial	O
dose	O
since	O
his	O
symptoms	O
were	O
felt	O
to	O
be	O
largely	O
reflective	O
of	O
CHF	O
exacerbation	O
in	O
the	O
presence	O
of	O
clinical	O
hypervolemia	O
and	O
in	O
the	O
absence	O
of	O
prominent	O
wheeze.	O
Albuterol/ipratropium	O
nebs	O
were	O
continued	O
throughout.	O
#CKI:	O
Cr	O
of	O
1.3	O
on	O
admission,	O
c/w	O
baselin,	O
remained	O
relatively	O
stable	O
throughout	O
(1.3-1.5)	O
despite	O
aggressive	O
diuresis.	O
#AF	O
on	O
ASA:	O
Admission	O
EKG	O
demonstrated	O
AF,	O
but	O
he	O
remained	O
in	O
SR	O
thereafter	O
and	O
V-paced	O
at	O
60bpm.	O
He	O
is	O
on	O
ASA	O
325mg	O
as	O
an	O
outpatient	O
in	O
place	O
of	O
Coumadin	O
due	O
to	O
h/o	O
falls	B-Falls
and	O
supratherapeutic	O
INR	O
(as	O
high	O
as	O
9.7	O
in	O
___	O
c/b	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed,	B-Upper_gastrointestinal_haemorrhage
and	O
ASA	O
was	O
continued	O
on	O
this	O
admission.	O
#Thrombocytopenia:	O
He	O
displayed	O
stable	O
thrombocytopenia	O
(100s-140s)	O
throughout	O
admission,	O
c/w	O
baseline,	O
without	O
active	O
signs	O
of	O
bleeding.	O
Further	O
evaluation	O
was	O
deferred	O
to	O
the	O
outpatient	O
setting.	O
#CAD/HTN:	O
Home	O
atenolol,	O
lisinopril,	O
and	O
ASA	O
were	O
continued	O
on	O
this	O
admission.	O
#Dementia:	O
Patient	O
with	O
h/o	O
dementia	B-Dementia
of	O
uncertain	O
etiology	O
was	O
rarely	O
agitated,	O
but	O
largely	O
calmly	O
AOx1/confused	I-Delirium
throughout	O
admission.	O
#BPH:	O
Home	O
tamsulosin	O
was	O
continued	O
on	O
this	O
admission.	O
#Transitional	O
issues:	O
-Acute-on-chronic	O
CHF:	O
Home	O
atenolol	O
was	O
continued	O
on	O
the	O
current	O
admission,	O
but	O
switch	O
to	O
metoprolol	O
or	O
carvedilol	O
may	O
be	O
considered	O
on	O
PCP	O
___	O
for	O
maximal	O
therapeutic	O
benefit.	O
-AF	O
on	O
ASA:	O
ASA	O
was	O
continued	O
for	O
prophylactic	O
management,	O
given	O
h/o	O
falls	B-Falls
and	O
supratherapeutic	O
INR,	O
but	O
anticoagulation	O
with	O
warfarin	O
or	O
Pradaxa	O
may	O
be	O
considered	O
on	O
PCP	O
___	O
if	O
felt	O
to	O
be	O
appropriate.	O
-Thrombocytopenia:	O
Low	O
platelet	O
count	O
was	O
stable	O
without	O
active	O
signs	O
of	O
bleeding,	O
and	O
further	O
evaluation	O
was	O
deferred	O
to	O
PCP	O
___.	O
Medications	O
on	O
Admission:	O
Preadmission	O
medications	O
listed	O
are	O
correct	O
and	O
complete.	O
Information	O
was	O
obtained	O
from	O
PCP.	O
1.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
2.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
3.	O
Atenolol	O
50	O
mg	O
PO	O
DAILY	O
4.	O
Furosemide	O
40	O
mg	O
PO	O
DAILY	O
5.	O
Lisinopril	O
2.5	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
2.	O
Atenolol	O
50	O
mg	O
PO	O
DAILY	O
3.	O
Furosemide	O
40	O
mg	O
PO	O
DAILY	O
4.	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
5.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
acute	O
respiratory	O
failure	O
requiring	O
mechanical	O
ventilation	O
Acute-on-chronic	O
diastolic	O
congestive	O
heart	O
failure	O
Chronic	O
obstructive	O
pulmonary	O
disease,	O
exacerbation	O
afib	O
Discharge	O
Condition:	O
Discharge	O
condition:	O
Improved	O
Mental	O
status:	O
Oriented	B-Unspecified_cognitive_impairment
to	O
self,	O
reportedly	O
consistent	O
with	O
baseline	O
dementia	B-Dementia
Ambulatory	O
status:	O
With	O
___,	O
consistent	O
with	O
baseline	O
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
participating	O
in	O
your	O
care	O
while	O
you	O
were	O
admitted	O
to	O
___.	O
As	O
you	O
know,	O
you	O
were	O
admitted	O
for	O
shortness	O
of	O
breath	O
and	O
arrived	O
from	O
another	O
hospital	O
with	O
a	O
tube	O
down	O
your	O
throat	O
on	O
a	O
ventilator	O
for	O
help	O
with	O
your	O
breathing.	O
After	O
the	O
tube	O
was	O
removed,	O
you	O
were	O
able	O
to	O
breathe	O
well	O
on	O
your	O
own	O
with	O
supplemental	O
oxygen,	O
which	O
you	O
use	O
at	O
home.	O
Your	O
shortness	O
of	O
breath	O
was	O
likely	O
due	O
to	O
fluid	O
in	O
your	O
lungs,	O
and	O
you	O
received	O
increased	O
doses	O
of	O
your	O
home	O
diuretic	O
(Lasix)	O
to	O
remove	O
the	O
fluid.	O
It	O
will	O
be	O
important	O
to	O
continue	O
to	O
take	O
Lasix	O
at	O
home	O
to	O
ensure	O
that	O
fluid	O
does	O
not	O
reaccumulate	O
in	O
your	O
lungs.	O
Given	O
the	O
possibility	O
that	O
your	O
chronic	O
obstructive	O
pulmonary	O
disease	O
(COPD)	O
was	O
contributing	O
to	O
your	O
shortness	O
of	O
breath,	O
you	O
also	O
received	O
steroids	O
to	O
help	O
with	O
your	O
breathing.	O
Followup	O
Instructions:	O
___	O

